← Leaderboards
Todd C McDevitt
Georgia Institute Of Technology
$8,030,444
Attributed
$8,375,592
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–20$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,375,592 · 9
By mechanism
R01$5,256,179 · 4
U01$2,183,290 · 3
R21$936,123 · 2
Top collaborators
- Ken Nakamura1 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Andres J Garcia$26,499,681
- Mark R Prausnitz$16,440,387
- Thomas Harrison Barker$9,624,712
- James Dahlman$4,346,621
- Anamik Jhunjhunwala$98,512
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsStem CellsEngineeringTissuesBaseCell TypePluripotent Stem CellsResearch PersonnelTranslatingPhenotypeIn VitroEmbryonic Stem CellMolecularCell TherapyExtracellularCellularityMorphogenesisDegenerative DisorderInjuryIn VivoTechnologySourceInnovationCell Differentiation Process
Grant awards (24)
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing$720,836
U01 · FY2020 · ES · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$690,296
R01 · FY2020 · AG
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing$720,269
U01 · FY2019 · EB · contact PI
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing$742,185
U01 · FY2018 · HL · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$414,192
R01 · FY2015 · AR · contact PI
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation$283,950
R21 · FY2015 · AI · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$216,591
R01 · FY2014 · AR · contact PI
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation$213,613
R21 · FY2014 · AI · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$166,637
R01 · FY2014 · AR · contact PI
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation$23,057
R21 · FY2014 · AI · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$364,963
R01 · FY2013 · AR · contact PI
Microsphere-mediated differentiation of embryonic stem cells$284,768
R01 · FY2013 · GM · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$376,250
R01 · FY2012 · AR · contact PI
Microsphere-mediated differentiation of embryonic stem cells$372,174
R01 · FY2012 · GM · contact PI
Microfluidic perfusion control of embryonic stem cell differentiation$316,646
R01 · FY2012 · EB · contact PI
Microsphere-mediated differentiation of embryonic stem cells$399,910
R01 · FY2011 · GM · contact PI
Stem Cell Morphogen Delivery via Engineered Biomaterials$376,250
R01 · FY2011 · AR · contact PI
Microfluidic perfusion control of embryonic stem cell differentiation$318,852
R01 · FY2011 · EB · contact PI
Microsphere-mediated differentiation of embryonic stem cells$27,988
R01 · FY2011 · GM · contact PI
Microfluidic perfusion control of embryonic stem cell differentiation$330,805
R01 · FY2010 · EB · contact PI
Microsphere-mediated differentiation of embryonic stem cells$292,017
R01 · FY2010 · GM · contact PI
Microsphere-mediated differentiation of embryonic stem cells$307,840
R01 · FY2009 · GM · contact PI
Regenerative acellular biomaterials derived from embryonic stem cells$189,047
R21 · FY2008 · EB · contact PI
Regenerative acellular biomaterials derived from embryonic stem cells$226,456
R21 · FY2007 · EB · contact PI